These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1550002)
21. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444 [TBL] [Abstract][Full Text] [Related]
22. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease. Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319 [TBL] [Abstract][Full Text] [Related]
23. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Wilber DJ; Olshansky B; Moran JF; Scanlon PJ Circulation; 1990 Aug; 82(2):350-8. PubMed ID: 2372886 [TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans. Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869 [TBL] [Abstract][Full Text] [Related]
25. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias. Kuchar DL; Garan H; Ruskin JN Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008 [TBL] [Abstract][Full Text] [Related]
26. The long-term prognosis of patients with out-of-hospital cardiac arrest but no inducible ventricular tachycardia. Sager PT; Choudhary R; Leon C; Rahimtoola SH; Bhandari AK Am Heart J; 1990 Dec; 120(6 Pt 1):1334-42. PubMed ID: 2248180 [TBL] [Abstract][Full Text] [Related]
27. Electrophysiologic testing and follow-up of patients with aborted sudden death. Eldar M; Sauve MJ; Scheinman MM J Am Coll Cardiol; 1987 Aug; 10(2):291-8. PubMed ID: 3598002 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. Poole JE; Mathisen TL; Kudenchuk PJ; McAnulty JH; Swerdlow CD; Bardy GH; Greene HL J Am Coll Cardiol; 1990 Sep; 16(3):657-65. PubMed ID: 2387939 [TBL] [Abstract][Full Text] [Related]
29. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507 [TBL] [Abstract][Full Text] [Related]
30. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents. Kudenchuk PJ; Kron J; Walance C; McAnulty JH Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683 [TBL] [Abstract][Full Text] [Related]
31. Predictors of sustained ventricular tachycardia inducibility in patients with nonsustained ventricular tachycardia and chronic coronary artery disease. Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW Am Heart J; 1989 May; 117(5):1050-9. PubMed ID: 2711964 [TBL] [Abstract][Full Text] [Related]
32. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764 [TBL] [Abstract][Full Text] [Related]
33. [Arrhythmia and anti-arrhythmia therapy as prognostic risks]. Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298 [TBL] [Abstract][Full Text] [Related]
34. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing]. Borggrefe M; Breithardt G Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680 [TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies. Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509 [TBL] [Abstract][Full Text] [Related]
36. [Are anti-arrhythmia agents superior to a beta blocker in treating life-threatening ventricular arrhythmias? Preliminary results of a controlled study]. Steinbeck G; Andresen D; von Leitner ER Z Kardiol; 1986; 75 Suppl 5():47-55. PubMed ID: 2435071 [TBL] [Abstract][Full Text] [Related]
38. Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia. Hammill SC; Trusty JM; Wood DL; Bailey KR; Vatterott PJ; Osborn MJ; Holmes DR; Gersh BJ Am J Cardiol; 1990 Mar; 65(11):722-8. PubMed ID: 2316454 [TBL] [Abstract][Full Text] [Related]
39. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias. Borggrefe M; Trampisch HJ; Breithardt G J Am Coll Cardiol; 1988 Jul; 12(1):140-9. PubMed ID: 3379199 [TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic studies before and after myocardial revascularization in patients with life-threatening ventricular arrhythmias. Garan H; Ruskin JN; DiMarco JP; Derkac WM; Akins CW; Daggett WM; Austen WG; Buckley MJ Am J Cardiol; 1983 Feb; 51(3):519-24. PubMed ID: 6600577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]